A recent multinational study published in eClinicalMedicine has raised serious concerns about the quality of antidiabetic medicines in sub-Saharan Africa. Conducted across 13 countries between 2020 and 2023, the DIABDAF study analysed nearly 5,000 samples of oral drugs and insulin, with detailed testing on 1,673. Alarmingly, almost one in three medicines (32.8%) were found to be ...







